We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
Cap. Flow
-$1.62B
Cap. Flow %
-9.46%
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$62M
2
AMZN icon
Amazon
AMZN
+$53.3M
3
CVS icon
CVS Health
CVS
+$40.3M
4
PYPL icon
PayPal
PYPL
+$34.8M
5
MCD icon
McDonald's
MCD
+$34.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$56.8M
2
EXE
Expand Energy Corp
EXE
+$43.4M
3
CHTR icon
Charter Communications
CHTR
+$42.4M
4
CMCSA icon
Comcast
CMCSA
+$40.3M
5
MA icon
Mastercard
MA
+$37.3M

Sector Composition

Rank Sector Weight
1 Financials 12.54%
2 Technology 11.9%
3 Consumer Discretionary 9.76%
4 Healthcare 8.91%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEXA icon
4476
Nexa Resources
NEXA
$1.87B
-85,186
Closed -$440K
NGVC icon
4477
Vitamin Cottage Natural Grocers
NGVC
$654M
-10,301
Closed -$111K
NLY icon
4478
Annaly Capital Management
NLY
$17.4B
-829,792
Closed -$14.2M
NMFC icon
4479
New Mountain Finance
NMFC
$732M
-11,246
Closed -$130K
NNN icon
4480
NNN REIT
NNN
$8.99B
-3,005
Closed -$120K
NRG icon
4481
CALL
NRG Energy
NRG
$24.8B
-12,400
Closed -$475K
NRG icon
4482
PUT
NRG Energy
NRG
$24.8B
-46,400
Closed -$1.78M
NRIX icon
4483
Nurix Therapeutics
NRIX
$2.65B
-131,919
Closed -$1.72M
NTGR icon
4484
NETGEAR
NTGR
$635M
-15,678
Closed -$314K
DFNS
4485
T3 Defense Inc
DFNS
$38.3M
-61
Closed -$461K
NUS icon
4486
Nu Skin
NUS
$267M
-72,300
Closed -$2.41M
NUTX
4487
Nutex Health
NUTX
$1.11B
-68
Closed -$15K
NVCR icon
4488
NovoCure
NVCR
$1.91B
-71,463
Closed -$5.43M
NVEE
4489
DELISTED
NV5 Global
NVEE
-17,912
Closed -$554K
NVGS icon
4490
Navigator Holdings
NVGS
$1.28B
-19,635
Closed -$225K
NVMI
4491
Nova
NVMI
$12.5B
-10,384
Closed -$886K
NVO
4492
CALL
Novo Nordisk
NVO
$209B
-9,200
Closed -$458K
NWN icon
4493
Northwest Natural Holdings
NWN
$2.12B
-15,790
Closed -$685K
NXPI icon
4494
PUT
NXP Semiconductors
NXPI
$60.4B
-5,200
Closed -$767K
NXTC icon
4495
NextCure
NXTC
$26.7M
-1,014
Closed -$33K
O icon
4496
Realty Income
O
$59.1B
-70,592
Closed -$4.11M
OCGN icon
4497
Ocugen
OCGN
$434M
-248
Closed
OCUL icon
4498
Ocular Therapeutix
OCUL
$2.02B
-48,210
Closed -$200K
IMDX
4499
Insight Molecular Diagnostics
IMDX
$156M
-2,036
Closed -$30K
OM icon
4500
Outset Medical
OM
$90.8M
-7,874
Closed -$1.88M

Similar funds

Cubist Systematic Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.

  • Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
  • Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
  • Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
  • Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
  • Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
  • Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.